An investigational ovarian stimulation protocol increased significantly the psychological burden in women with premature ovarian failure

Acta Obstet Gynecol Scand. 2012 Nov;91(11):1273-8. doi: 10.1111/aogs.12004.

Abstract

Objective: To assess the psychological impact (Hospital Anxiety and Depression Scale) of an investigational ovarian stimulation protocol in women with premature ovarian failure (POF).

Design: Prospective longitudinal study.

Population: Ten women with POF.

Methods: Women with idiopathic POF were placed on three consecutive treatment cycles consisting of gonadotropin ovarian stimulation after estrogen priming, gonadotropin-releasing hormone agonist pituitary desensitization, and corticosteroid immune suppression.

Results: Median anxiety and depression scores increased significantly from baseline following three consecutive treatment cycles from 4.0 (range 2.0-8.0) to 11.0 (range 10.0-14.0) (p-value 0.041) and from 1.5 (range 0-6.0) to 9.0 (range 7.0-10.0) (p-value 0.039), respectively. There were nine "probable" anxiety (90%) and three "probable" depression (30%) cases on the final treatment cycle compared with none (0%) on baseline (p-value 0.004 and 0.250, respectively).

Conclusions: The use of investigational ovarian stimulation protocols in women with idiopathic POF was associated with excessive psychological strain. Women with POF should be cautioned against the potentially harmful aspect of similar treatments of unproven benefit.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Anxiety / etiology
  • Buserelin / therapeutic use
  • Chorionic Gonadotropin / therapeutic use
  • Depression / etiology
  • Estrogens / therapeutic use
  • Estrogens, Conjugated (USP) / therapeutic use
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Infertility, Female / etiology
  • Infertility, Female / psychology
  • Infertility, Female / therapy*
  • Insemination, Artificial
  • Longitudinal Studies
  • Medroxyprogesterone Acetate / therapeutic use
  • Menotropins / therapeutic use
  • Ovary / diagnostic imaging
  • Ovulation Induction*
  • Prednisone / therapeutic use
  • Primary Ovarian Insufficiency / complications
  • Primary Ovarian Insufficiency / psychology*
  • Prospective Studies
  • Psychiatric Status Rating Scales
  • Reproductive Control Agents / therapeutic use
  • Ultrasonography
  • Young Adult

Substances

  • Chorionic Gonadotropin
  • Estrogens
  • Estrogens, Conjugated (USP)
  • Glucocorticoids
  • Reproductive Control Agents
  • Menotropins
  • Medroxyprogesterone Acetate
  • Buserelin
  • Prednisone